Search research articles
Contact Us
Filters
Showing results (21-30 of 40) with videos related to
Page
of 4
Sort By:
Journal of Medicinal Chemistry
|
March 15, 2016
Tuning Side Arm Electronics in Unsymmetrical Cyclotriazadisulfonamide (CADA) Endoplasmic Reticulum (ER) Translocation Inhibitors to Improve their Human Cluster of Differentiation 4 (CD4) Receptor Down-Modulating Potencies
Reena Chawla, Victor Van Puyenbroeck, Nicholas C Pflug, et al.
Organic & Biomolecular Chemistry
|
September 5, 2015
Metal complexes of pyridine-fused macrocyclic polyamines targeting the chemokine receptor CXCR4
Sunil Hamal, Thomas D'huys, William F Rowley, et al.
Current HIV Research
|
May 14, 2008
CADA, a potential anti-HIV microbicide that specifically targets the cellular CD4 receptor
Kurt Vermeire, Joachim Brouwers, Yven Van Herrewege, et al.
European Journal of Medicinal Chemistry
|
December 21, 2022
Isoform selectivities of novel 4-hydroxycoumarin imines as inhibitors of myosin II
Joshua D Smith, Jhonnathan Brawley, Kate C Bordenave, et al.
Journal of Nanoparticle Research : an Interdisciplinary Forum for Nanoscale Science and Technology
|
January 11, 2014
Cadmium and Zinc Alloyed Cu-In-S Nanocrystals and Their Optical Properties
Liming Huang, Xiaoshan Zhu, Nelson G Publicover, et al.
Biochemical Pharmacology
|
July 3, 2007
Design and cellular kinetics of dansyl-labeled CADA derivatives with anti-HIV and CD4 receptor down-modulating activity
Kurt Vermeire, Andrea Lisco, Jean-Charles Grivel, et al.
AIDS Research and Therapy
|
June 16, 2010
Differential activity of candidate microbicides against early steps of HIV-1 infection upon complement virus opsonization
Mohammad-Ali Jenabian, Héla Saïdi, Charlotte Charpentier, et al.
Molecular Pharmacology
|
December 19, 2002
The Anti-HIV potency of cyclotriazadisulfonamide analogs is directly correlated with their ability to down-modulate the CD4 receptor
Kurt Vermeire, Thomas W Bell, Heung-Jin Choi, et al.
Bioorganic & Medicinal Chemistry
|
November 12, 2020
Syntheses and anti-HIV and human cluster of differentiation 4 (CD4) down-modulating potencies of pyridine-fused cyclotriazadisulfonamide (CADA) compounds
Liezel A Lumangtad, Elisa Claeys, Sunil Hamal, et al.
Plos Biology
|
December 3, 2014
Signal peptide-binding drug as a selective inhibitor of co-translational protein translocation
Kurt Vermeire, Thomas W Bell, Victor Van Puyenbroeck, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 40) with videos related to
Sort By:
Page
of 4
Journal of Medicinal Chemistry
|
March 15, 2016
Tuning Side Arm Electronics in Unsymmetrical Cyclotriazadisulfonamide (CADA) Endoplasmic Reticulum (ER) Translocation Inhibitors to Improve their Human Cluster of Differentiation 4 (CD4) Receptor Down-Modulating Potencies
Reena Chawla, Victor Van Puyenbroeck, Nicholas C Pflug, et al.
Organic & Biomolecular Chemistry
|
September 5, 2015
Metal complexes of pyridine-fused macrocyclic polyamines targeting the chemokine receptor CXCR4
Sunil Hamal, Thomas D'huys, William F Rowley, et al.
Current HIV Research
|
May 14, 2008
CADA, a potential anti-HIV microbicide that specifically targets the cellular CD4 receptor
Kurt Vermeire, Joachim Brouwers, Yven Van Herrewege, et al.
European Journal of Medicinal Chemistry
|
December 21, 2022
Isoform selectivities of novel 4-hydroxycoumarin imines as inhibitors of myosin II
Joshua D Smith, Jhonnathan Brawley, Kate C Bordenave, et al.
Journal of Nanoparticle Research : an Interdisciplinary Forum for Nanoscale Science and Technology
|
January 11, 2014
Cadmium and Zinc Alloyed Cu-In-S Nanocrystals and Their Optical Properties
Liming Huang, Xiaoshan Zhu, Nelson G Publicover, et al.
Biochemical Pharmacology
|
July 3, 2007
Design and cellular kinetics of dansyl-labeled CADA derivatives with anti-HIV and CD4 receptor down-modulating activity
Kurt Vermeire, Andrea Lisco, Jean-Charles Grivel, et al.
AIDS Research and Therapy
|
June 16, 2010
Differential activity of candidate microbicides against early steps of HIV-1 infection upon complement virus opsonization
Mohammad-Ali Jenabian, Héla Saïdi, Charlotte Charpentier, et al.
Molecular Pharmacology
|
December 19, 2002
The Anti-HIV potency of cyclotriazadisulfonamide analogs is directly correlated with their ability to down-modulate the CD4 receptor
Kurt Vermeire, Thomas W Bell, Heung-Jin Choi, et al.
Bioorganic & Medicinal Chemistry
|
November 12, 2020
Syntheses and anti-HIV and human cluster of differentiation 4 (CD4) down-modulating potencies of pyridine-fused cyclotriazadisulfonamide (CADA) compounds
Liezel A Lumangtad, Elisa Claeys, Sunil Hamal, et al.
Plos Biology
|
December 3, 2014
Signal peptide-binding drug as a selective inhibitor of co-translational protein translocation
Kurt Vermeire, Thomas W Bell, Victor Van Puyenbroeck, et al.
Page
of 4